We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Chronic Oral Hydration in Patients With Recurrent Unexplained Syncope

This study has been terminated.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00143754
First Posted: September 2, 2005
Last Update Posted: December 9, 2005
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University Hospital, Angers
  Purpose
Beneficial effect of chronic hydration with salt supplementation in patients with recurrent unexplained syncope is not established. We sought to determine if chronic oral rehydration with salt supplementation improved the tolerance and hemodynamic responses of patients with unexplained recurrent syncope.

Condition Intervention Phase
Hydration Loss of Consciousness Neurocardiogenic Syncope Procedure: Hydration Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Official Title: Benefit of Controlled Rehydration in Unexplained Syncope

Resource links provided by NLM:


Further study details as provided by University Hospital, Angers:

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Syncopal and/or near syncopal episodes at least twice within the prior 3 months

Exclusion Criteria:

  • Neurological disease
  • Structural heart disease
  • Metabolic and psychiatric illness
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00143754


Sponsors and Collaborators
University Hospital, Angers
Investigators
Principal Investigator: Georges PN Leftheriotis, MD-PhD HUAngers
  More Information

ClinicalTrials.gov Identifier: NCT00143754     History of Changes
Other Study ID Numbers: CP00-02
Centre Evian pour l'Eau
First Submitted: August 31, 2005
First Posted: September 2, 2005
Last Update Posted: December 9, 2005
Last Verified: August 2005

Additional relevant MeSH terms:
Syncope
Unconsciousness
Consciousness Disorders
Neurobehavioral Manifestations
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms